Levocetirizine Dihydrochloride & Montelukast Oral Syrup – Lenzit-M

PRODUCT NAME: Levocetirizine Dihydrochloride & Montelukast Oral Syrup – Lenzit-M

Dosage Form: Syrup

Levocetirizine Dihydrochloride & Montelukast Oral Syrup – Lenzit-M a product is supplied in a 60 ml bottle, as shown on its packaging.

Levocetirizine is an antihistamine helps relieve allergy symptoms such as sneezing, runny nose, nasal itching and itchy or watery eyes. Montelukast works by blocking leukotrienes, substances in the body that contribute to allergic symptoms and inflammation in the airways. A healthcare professional may prescribe this combination for selected allergic conditions when both ingredients are considered appropriate.

Lenzit-M comes in a liquid oral dosage form, which may be useful for patients who have difficulty swallowing tablets. Its packaging features a dark blue, white and yellow colour scheme with clear brand identification.

The medicine should be used according to a healthcare professional’s advice, particularly when intended for children. The correct dose depends on the patient’s age, diagnosis and medical history. Montelukast carries an important warning regarding possible mood and behavioural changes, including serious mental health effects. Seek medical advice if unusual changes occur.

Before use, review the approved product label for the exact composition, dosing instructions, storage requirements and precautions. Consult a doctor or pharmacist if symptoms persist or other medicines are being taken.